These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. New insights into factors affecting clot stability: A role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R). Bouma BN; Meijers JC Semin Hematol; 2004 Jan; 41(1 Suppl 1):13-9. PubMed ID: 14872415 [TBL] [Abstract][Full Text] [Related]
4. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. Bajzar L; Morser J; Nesheim M J Biol Chem; 1996 Jul; 271(28):16603-8. PubMed ID: 8663147 [TBL] [Abstract][Full Text] [Related]
5. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)]. Urano T Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):298-303. PubMed ID: 11215380 [TBL] [Abstract][Full Text] [Related]
6. Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation. Antovic JP; Blombäck M Thromb Res; 2002 Apr; 106(1):59-62. PubMed ID: 12165290 [TBL] [Abstract][Full Text] [Related]
7. Proteolytic activation of purified human procarboxypeptidase U. Schatteman KA; Goossens FJ; Scharpé SS; Hendriks DF Clin Chim Acta; 2000 Feb; 292(1-2):25-40. PubMed ID: 10686274 [TBL] [Abstract][Full Text] [Related]
8. Factor XI dependent and independent activation of thrombin activatable fibrinolysis inhibitor (TAFI) in plasma associated with clot formation. Bouma BN; Mosnier LO; Meijers JC; Griffin JH Thromb Haemost; 1999 Dec; 82(6):1703-8. PubMed ID: 10613658 [TBL] [Abstract][Full Text] [Related]
9. [Thrombin activatable fibrinolysis inhibitor (TAFI) and its importance in the regulation of fibrinolysis]. Stasko J; Hudecek J; Kubisz P Vnitr Lek; 2004 Jan; 50(1):36-44. PubMed ID: 15015228 [TBL] [Abstract][Full Text] [Related]
10. The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent. Bajzar L; Nesheim ME; Tracy PB Blood; 1996 Sep; 88(6):2093-100. PubMed ID: 8822928 [TBL] [Abstract][Full Text] [Related]
11. Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease? Antovic JP; Schulman S; An SS; Greenfield RS; Blombäck M Scand J Clin Lab Invest; 2004; 64(8):745-51. PubMed ID: 15719893 [TBL] [Abstract][Full Text] [Related]
18. Total thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and pro-TAFI in patients with haemophilia A. Antovic J; Schulman S; Eelde A; Blombäck M Haemophilia; 2001 Nov; 7(6):557-60. PubMed ID: 11851753 [TBL] [Abstract][Full Text] [Related]
19. Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Nesheim M; Wang W; Boffa M; Nagashima M; Morser J; Bajzar L Thromb Haemost; 1997 Jul; 78(1):386-91. PubMed ID: 9198184 [TBL] [Abstract][Full Text] [Related]